Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20366 (
substance P
)
21,176
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Dysphagia induces silent aspiration, which is a known risk factor for aspiration pneumonia in the elderly. Dysphagia is associated with impaired
substance P
secretion. Because nicergoline was recently reported to enhance
substance P
secretion, it may improve dysphagia by upregulating
substance P
; however, roles for nicergoline in this process have not been demonstrated. We therefore compared the effects of nicergoline on serum
substance P
and dysphagia with the effects of imidapril, an angiotensin-converting enzyme (ACE) inhibitor whose efficacy in improving dysphagia and preventing pneumonia has been previously demonstrated.We randomly assigned 60 elderly patients with both dysphagia and a previous history of pneumonia to receive either imidapril (5 mg/d; n = 30) or nicergoline (15 mg/d; n = 30) for 6 months. Primary outcomes were the effects of these drugs on the
substance P
level and dysphagia 4 weeks after the start of treatment. Secondary outcome was the effect of these drugs on pneumonia recurrence during the 6 months of treatment.Significant elevations of serum
substance P
were obtained by both medications after 4 weeks of treatment. Patients whose dysphagia was improved showed significantly increased serum levels of
substance P
. There was no statistically significant difference in the overall proportion of patients who showed improvements in dysphagia and pneumonia recurrence with imidapril or nicergoline treatment.
Nicergoline
, but not imidapril, seemed to be more effective at improving dysphagia and elevating serum
substance P
in patients with dementia.In conclusion, nicergoline has a comparable effect to ACE inhibitors for improving dysphagia.
Nicergoline
might be a novel regimen for the treatment of dysphagia in the elderly who are not treatable with ACE inhibitors.
...
PMID:Nicergoline improves dysphagia by upregulating substance P in the elderly. 2169 49